SALSA MLPA P175 Tumour Gain probemiximproved

application: Tumour Gain
region: various
[login for my products]
version: B1

item no. description price
P175-025R SALSA MLPA P175 Tumour Gain probemix – 25 rxn € 237
P175-050R SALSA MLPA P175 Tumour Gain probemix – 50 rxn € 474
P175-100R SALSA MLPA P175 Tumour Gain probemix – 100 rxn € 948
EK1-FAM SALSA MLPA EK1 reagent kit – 100 rxn - FAM € 294
EK1-Cy5 SALSA MLPA EK1 reagent kit – 100 rxn - Cy5 € 294
EK5-FAM SALSA MLPA EK5 reagent kit – 500 rxn - FAM € 1355
EK5-Cy5 SALSA MLPA EK5 reagent kit – 500 rxn - Cy5 € 1355

Please note that both a probemix and reagent kit are needed to perform MLPA.

description
General information: The SALSA MLPA Probemix P175 Tumour Gain is a research use only (RUO) assay for the detection of copy number aberrations in 24 genes, which are frequently gained or amplified in various tumour types. This probemix can also be used to detect the presence of the BRAF p.V600E (c.1799T>A) point mutation.

Probemix content: The SALSA MLPA Probemix P175-B1 Tumour Gain contains 62 MLPA probes with amplification products between 115 and 504 nucleotides (nt). This includes two probes for the following genes: ABL1, ALK, AR, AURKA/B, BRAF, CCND1/2, CDK4, DHFR, EGFR, ERBB2, FGFR1, KDR, KIT, MDM2/4, MET, MYC, MYCN, PDGFRA, RET, SMO and TOP2A. Furthermore, it also contains one probe specific for the BRAF p.V600E (c.1799T>A) point mutation which will only generate a signal when the mutation is present. In addition, 13 reference probes are included and detect different autosomal chromosomal locations which are relatively stable in most tumour types. However, it should be noted that tumour karyotypes can harbour multiple numerical and structural aberrations, which can complicate interpretation of these reference probes. Complete probe sequences and the identity of the genes detected by the reference probes is available in Table 2b of the product description and online (www.mlpa.com).

This probemix contains nine quality control fragments generating amplification products between 64 and 121 nt: four DNA Quantity fragments (Q-fragments), two DNA Denaturation fragments (D-fragments), one Benchmark fragment, and one chromosome X and one chromosome Y-specific fragment. More information on how to interpret observations on these control fragments can be found in the MLPA General Protocol and online at www.mlpa.com.

SALSA Binning DNA SD029: The SD029 Binning DNA provided with this probemix can be used as Binning DNA sample for binning of one mutation-specific probe (BRAF probe 08780-SP0039-L08904 for the p.V600E (c.1799T>A) point mutation). SD029 Binning DNA is a mixture of genomic DNA from healthy individuals and plasmid DNA that contains the target sequence detected by the above mentioned probe. Inclusion of one reaction with 5 μl SD029 Binning DNA in initial MLPA experiments is essential as it can be used to aid in data binning of the peak pattern using Coffalyser.Net software. Furthermore, Binning DNA should be included in the experiment whenever changes have been applied to the set-up of the capillary electrophoresis device (e.g. when capillaries have been renewed). Binning DNA should never be used as a reference sample in the MLPA data analysis, neither should it be used in quantification of the mutation signal, as for this purpose true mutation positive patient samples or cell lines should be used. It is strongly advised to use test DNA sample and reference DNA samples extracted with the same method and derived from the same source of tissue. For further details, please consult the SD029 Binning DNA product description provided. This product is for research use only (RUO).

sample DNA
Sample DNA developed for this product:

related products
SALSA MLPA P294 Tumour Loss probemix
Contains probes for 1p36, 13q14 (RB1), AMER1, APC, BRCA1/2, CDKN2A/B, FHIT, FKBP8, NF1, PTCH1, PTEN, SMAD4, SMARCB1, STK11, TP53, TSC1/2, VHL, and WT1.

product history
version B1: Six target probes have been replaced and one has been removed. In total 13 reference probes have been added, and multiple probes have a change in length but not in the sequence detected.
version A3: Small change in length of 9 probes.
version A2: Two probes have a small change in length and the 88 and 96 nt control fragments have been replaced (QDX2).
version A1: changes not specified

new products
P476-ZNRF3
Adrenocortical tumours and other solid tumours
improved products
P175-Tumour Gain
Tumour Gain
P260-PALB2-RAD50-RAD51C-RAD51D
Hereditary predisposition to Cancer
P103-DPYD
Dihydropyrimidine dehydrogenase (DPYD) deficiency
P152-ABCA4 mix-2
Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration, cone rod dystrophies
P151-ABCA4 mix-1
Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration, cone rod dystrophies
P267-Dandy-Walker
Dandy-Walker Malformation (DWM)
P226-SDH
Paragangliomas (PGL)
P335-ALL-IKZF1
ALL
P340-EHMT1
9q subtelomeric deletion syndrome (9qSTDS) or Kleefstra syndrome.
Newsletter  |  Home  |  Site map  |  Terms and Conditions  |  Search  |  Copyright © 2018 MRC-Holland